Skip to main content
SpringerLink
Log in

Factors affecting the treatment of multiple colorectal adenomas

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Currently, no guidelines exist for the treatment of patients with multiple colorectal adenomas (MCRAs) (>10 but <100 synchronous nondiminutive polyps of the large bowel). This retrospective study aimed to investigate the clinical and molecular factors related to different treatments for MCRAs.

Methods

Patients with MCRAs were consecutively enrolled from January 2003 to June 2011. Sequencing of their APC and MutYH genes was performed. The clinical, molecular, and family histories of the patients were collected using the Progeny database. The patient treatments were divided into three groups of increasing clinical weight: endoscopic polypectomy, segmental resection, and total colectomy. A logistic regression analysis of clinicomolecular factors related to different treatment options was performed.

Results

The study comprised 80 patients (32 women, 40 %) with a median age of 53 years (range 13–74 years). The median number of polyps was 33 (range 10–90).The cases included 62 diffuse polyposis, 18 segmental polyposis coli and synchronous colorectal carcinomas (CRC; 34 cases, 43%). The pathogenetic mutations were biallelic MutYH (n = 19, 24 %) and APC (n = 4, 5 %). The mean follow-up period was 74 months (median 43 months, range 1–468 months). Endoscopic polypectomy was performed in 25 cases (31 %), segmental resection in 16 cases (20 %), and total colectomy in 39 cases (49 %). The logistics regression analysis, considering all the patients, showed that the number of polyps, the presence of CRC, and mutation were correlated with more intensive treatment. For the patients without CRC, only the number of polyps was correlated with the severity of the treatment (p > 0.0166). “On the ROC (receiver operating characteristic) curve, 25 was the number of polyps that best discriminated between surgical and endoscopic therapy.

Conclusions

The majority of patients with MCRAs undergo surgery. For patients without CRC, only the number of polyps, and not the presence of a disease-causing mutation, is correlated with increased heaviness of treatment. Patients with more than 25 polyps are more likely to undergo a surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600

    Article  PubMed  Google Scholar 

  2. Phillips RKS, Spigelman AD (1996) Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis? Br J Sur 83:769–770

    Article  CAS  Google Scholar 

  3. Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church J, Phillips RK, Tekkis PP (2006) Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 93:407–417

    Article  PubMed  CAS  Google Scholar 

  4. Thirlwell C, Howarth KM, Segditsas S, Guerra G, Thomas HJ, Phillips RK, Talbot IC, Gorman M, Novelli MR, Sieber OM, Tomlinson IP (2007) Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germiline APC or MYH/MUTYH mutation. Br J Cancer 96:1729–1734

    Article  PubMed  CAS  Google Scholar 

  5. Nielsen M, Hes FJ, Nagengast FM, Weiss MM, Mathus-Vliegen EM, Morreau H, Breuning MH, Wijnen JT, Tops CM, Vasen HF (2007) Germline mutations is APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71:427–433

    Article  PubMed  CAS  Google Scholar 

  6. Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, Bisgaard ML, Orntoft TF, Aaltonen LA, Hodgson SV, Thomas HJ, Tomlinson IP (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH. N Engl J Med 348:791–799

    Article  PubMed  Google Scholar 

  7. O’Shea AM, Cleary SP, Croitoru MA, Kim H, Berk T, Monga N, Riddell RH, Pollett A, Gallinger S (2008) Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology 53:184–194

    Article  PubMed  Google Scholar 

  8. Knudsen AL, Bisgaard ML, Bülow S (2003) Attenuated familial adenomatous polyposis (AFAP): a review of the literature. Fam Cancer 2:43–55

    Article  PubMed  Google Scholar 

  9. van der Luijt RB, Vasen HF, Tops CM, Breukel C, Fodde R, Meera Khan P (1995) APC mutation in the alternatively spliced region of exon 9 associated with late-onset familial adenomatous polyposis. Hum Genet 96:705–710

    Article  PubMed  Google Scholar 

  10. Filipe B, Baltazar C, Albuquerque C, Fragoso S, Lage P, Vitoriano I, Mão de Ferro S, Claro I, Rodrigues P, Fidalgo P, Chaves P, Cravo M, Nobre Leitão C (2009) APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Clin Genet 76:242–255

    Article  PubMed  CAS  Google Scholar 

  11. Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC, French AJ, Johnson RA, Burgart LJ, Rabe K, Lindor NM, Thibodeau SN (2004) MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127:9–16

    Article  PubMed  CAS  Google Scholar 

  12. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP (2002) Inherited variants of MYH associated with somatic G:C→T:a mutations in colorectal tumors. Nat Genet 30:227–232

    Article  PubMed  CAS  Google Scholar 

  13. Poulsen ML, Bisgaard ML (2008) MUTYH associated polyposis (MAP). Curr Genomics 9:420–435

    Article  PubMed  CAS  Google Scholar 

  14. Morak M, Laner A, Bacher U, Keiling C, Holinski-Feder E (2010) MUTYH-associated polyposis: variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations. Clin Genet 78:353–363

    Article  PubMed  CAS  Google Scholar 

  15. Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bülow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Järvinen H, Mecklin JP, Møller P, Myrhøi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713

    Article  PubMed  CAS  Google Scholar 

  16. Nascimbeni R, Pucciarelli S, Di Lorenzo D, Urso E, Casella C, Agostini M, Nitti D, Salerni B (2010) Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis. Dis Colon Rectum 53:1670–1675

    Article  PubMed  Google Scholar 

  17. Agostini M, Bedin C, Pucciarelli S, Enzo M, Briarava M, Seraglia R, Ragazzi E, Traldi P, Molin L, Urso ED, Mammi I, Viel A, Lise M, Tasciotti E, Biasiolo A, Pontisso P, Nitti D.(2012) APC I1307 K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. Int J Biol Markers 27:13–9 doi:10.5301/JBM.2011.8908

    Article  PubMed  Google Scholar 

  18. Knudsen AL, Bülow S, Tomlinson I, Möslein G, Heinimann K, Christensen IJ; AFAP Study Group (2010) Attenuated familial adenomatous polyposis: results from an international collaborative study. Colorectal Dis 12(10 online):e243–e249

    Google Scholar 

  19. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101:343–350

    Article  PubMed  Google Scholar 

  20. Sanaka MR, Deepinder F, Thota PN, Lopez R, Burke CA (2009) Adenomas are detected more often in morning than in afternoon colonoscopy. Am J Gastroenterol 104:1659–1664

    Article  PubMed  Google Scholar 

  21. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S, Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network (2008) Missed adenomas during colonoscopic surveillance in individuals with Lynch syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res 1:470–475

    Article  Google Scholar 

  22. Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, Sautereau D, Boustière C, Grimaud JC, Barthélémy C, Sée J, Serraj I, D’Halluin PN, Branger B, Ponchon T (2008) Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40:284–290

    Article  PubMed  CAS  Google Scholar 

  23. Waye JD, Lewis BS, Yessayan S (1992) Colonoscopy: a prospective report of complications. J Clin Gastroenterol 15:347–351

    Article  PubMed  CAS  Google Scholar 

  24. Rex DK, Lewis BS, Waye JD (1992) Colonoscopy and endoscopic therapy for delayed post-polypectomy hemorrhage. Gastrointest Endosc 38:127–129

    Article  PubMed  CAS  Google Scholar 

  25. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual (2010, seventh edition). Retrieved at http://www.cancerstaging.org

  26. Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J, Kitajima M (2004) The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 51:998–1000

    PubMed  Google Scholar 

  27. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206

    Article  PubMed  Google Scholar 

  28. Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy AM (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6:477–484

    Article  PubMed  Google Scholar 

  29. Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60:950–957

    Article  PubMed  Google Scholar 

  30. Nascimbeni R, Urso E, Pucciarelli S, et al (2012) High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling Amsterdam criteria. Ann Surg In press

  31. Natarajan N, Watson P, Silva-Lopez E, Lynch HT (2010) Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 53:77–82

    Article  PubMed  Google Scholar 

Download references

Disclosures

Emanuele D. L. Urso, Riccardo Nascimbeni, Salvatore Pucciarelli, Marco Agostini, Claudio Casella, Dario Moneghini, Diego Di Lorenzo, Isacco Maretto, Maribel Sullivan, Isabella Mammi, Alessandra Viel, and Donato Nitti have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Azienda Ospedaliera University of Padova, Via Giustiniani, 2, 35128, Padova, Italy

    Emanuele D. L. Urso, Salvatore Pucciarelli, Marco Agostini, Isacco Maretto, Maribel Sullivan, Isabella Mammi & Donato Nitti

  2. Dipartimento di Scienze Mediche & Chirurgiche, University of Brescia, Brescia, Italy

    Riccardo Nascimbeni, Claudio Casella, Dario Moneghini & Diego Di Lorenzo

  3. Oncologia Sperimentale 1, Centro Regionale Oncologico (CRO), Aviano, Aviano, Italy

    Alessandra Viel

  4. Dipartimento di Scienze Oncologiche e Chirurgiche, Clinica Chirurgica II, Policlinico, VI piano, Via Giustiniani, 2, 35128, Padova, Italy

    Emanuele D. L. Urso

Authors
  1. Emanuele D. L. Urso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riccardo Nascimbeni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salvatore Pucciarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Agostini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudio Casella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dario Moneghini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Diego Di Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Isacco Maretto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maribel Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Isabella Mammi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Alessandra Viel
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Donato Nitti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuele D. L. Urso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urso, E.D.L., Nascimbeni, R., Pucciarelli, S. et al. Factors affecting the treatment of multiple colorectal adenomas. Surg Endosc 27, 207–213 (2013). https://doi.org/10.1007/s00464-012-2421-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-012-2421-2

Keywords

Search

Navigation